PHAXIAM Therapeutics S.A. Overview

PHAXIAM Therapeutics S.A. EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PHXM.

Quarterly EBIT

-$12.31M

↓ 559.67% YoY

As of Dec 31, 2023

Annual EBIT (TTM)

-$15.38M

↑ 17.4% YoY

Trailing 12 months ending Dec 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin